Emkay initiates India's Sagility at 'Buy' with street-high PT
BUZZ-Emkay initiates India's Sagility at 'Buy' with street-high PT ** Emkay starts coverage on health tech provider Sagility SAGL.NS with a "Buy" and a street high PT of 55 rupees according to data compiled by LSEG
** Brokerage expects ~15% revenue CAGR and ~20% EPS CAGR over FY26-29, supported by deeper penetration in existing accounts, expansion into adjacent workflows, cross-selling and M&A-led capabilities
** Sees structural growth support from U.S. healthcare outsourcing as rising healthcare costs, regulatory complexity and pressure on payers to improve efficiency drive demand
** Key risks include slower U.S. healthcare spending, client concentration, Medicare and Medicaid regulatory changes and greater-than-expected AI-led pricing pressure
** SAGL up 0.9% at 46.05 rupees; YTD down ~12%
(Reporting by Urvi Dugar in Bengaluru)
((UrviManoj.Dugar@thomsonreuters.com; +91 9558725583;))
Recent news on Sagility
See all newsJefferies sees re-rating potential for select IT stocks; sub-index jumps 2%
Emkay initiates India's Sagility at 'Buy' with street-high PT
Brief: Sagility Ltd June-Quarter Consol Net Profit 2.17 Billion Rupees
Brief: Sagility Signs Definitive Agreement For Acquisition Of Careseed
Brief: Sagility Receives Tax Order With Demand Of 9 Million Rupees For April 2022-March 2023